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Abstract
The binding of [3H]ketanserin to goldfish and rabbit retinal membrane preparations and the possible role of 5-HT2A receptors
in the in vitro outgrowth from goldfish retina were evaluated. Saturation experiments indicated a high-affinity binding site, and
positive cooperativity for both tissues. The 5-HT2A:2C agonist (9 )-2,5-dimetoxy-4-iodoamphetamine and serotonin inhibited
outgrowth from goldfish retinal explants. These effects were blocked by the 5-HT2 antagonists ketanserin and 1-(1-naph-
thyl)piperazine and by the 5-HT2C antagonist mesulergine, respectively. Results make to suggest that [
3H]ketanserin binds to
5-HT2A receptors in the rabbit and goldfish retina, but also to a monoamine transporter in the latter tissue. Subtypes of 5-HT2
receptors might mediate the 5-HT modulatory role on in vitro outgrowth of the goldfish retina. © 1999 Elsevier Science Ltd. All
rights reserved.
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1. Introduction
Serotonin (5-HT) receptors are classified into two
different superfamilies, the G protein-coupled receptors
and the ligand-gated ion channels (Alexander & Peters,
1998). 5-HT1 and 5-HT2 belong to the first group, and
the 5-HT3 to the latter. 5-HT1 receptors are negatively
coupled to adenylate cyclase and the 5-HT2 receptor
family, which includes three subtypes, 5-HT2A, 5-HT2B
and 5-HT2C, are coupled to phosphoinositide hydrolysis
(Alexander & Peters, 1998).
Radioligand binding studies have revealed 5-HT2
receptor binding sites in the frontal, piriform, and
entorhinal cortex, as well as in the claustrum and in
brainstem motor nuclei from the rat (Leysen,
Niemegeer, Van Neuten & Laduron, 1982; Pazos, Cor-
tex & Palacios, 1985). 5-HT2 receptors mediate several
effects of 5-HT, including vascular and uterine smooth
muscle contraction (Cohen, Fuller & Wiley, 1981), and
are also related to psychiatric disorders like depression
and anxiety (Deakin, 1988). In the rat, 5-HT produces
a stimulatory effect on survival and growth of some
5-HT neurons at 14th embryonic day, an effect which
seems to be mediated by 5-HT2 receptors (Hellendall,
Schambra, Liu & Lauder, 1993).
5-HT1 and 5-HT2 subtypes (Mitchell & Redburn,
1985), and 5-HT3 (Barnes, Barnes, Brunken & Robert-
son, 1991) have been identified in the mammalian
retina. In the rabbit (Daw, Jensen & Brunken, 1990)
and the goldfish (Hensley & Cohen, 1992) retina 5-HT1
and 5-HT2 receptor agonists and antagonists modify
the activity of ON and OFF center ganglion cells
through the rod pathway. 5-HT increases phospho-
inositide turnover in rabbit retinal slices and this effect
can be reversibly blocked by 5-HT2A receptor antago-
nists which made to suggest that these receptors are
present in this tissue (Osborne & Ghazi, 1990). In the
goldfish retina, binding sites for the 5-HT1A receptor
agonist 8-[3H]hidroxy-2-(di-n-propylamino)tetralin
([3H]DPAT) (Lima, Schmeer & Urbina, 1994a) posi-
tively coupled to adenylate cyclase (Urbina, Schmeer &
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Lima, 1996) have been reported. In this tissue, 5-HT
and DPAT inhibit in vitro outgrowth after a lesion of
the optic nerve (Lima, Matus and Urbina, 1994b).
Despite evidence supporting its existence, there is a
controversy concerning the presence of 5-HT1A in the
retina (Urbina et al., 1996; Chidlow, Le Corre & Os-
borne, 1998).
Ketanserin, is a quinazoline derivative, which acts as
a 5-HT antagonist at 5-HT2A receptors (Leysen,
Awouters, Kennis, Laduron, Vandenberk & Janssen,
1981). Since its introduction as a selective radioligand
for 5-HT2 recognition sites, [3H]ketanserin has been
extensively used to study brain distribution (Pazos et
al., 1985). This ligand, although quite selective for
5-HT2 versus other 5-HT receptors, binds to histamine
and adrenergic receptors (Leysen et al., 1981) and labels
a monoamine transport site (Dewar, Lima & Reader,
1990). Nevertheless, it remains the prototypic antago-
nist and ligand for 5-HT2A receptors (Cortijo, Marti-
Cabrera, Bernabeu, Domenech, Bou, Ferna´ndez, et al.,
1997).
Since 5-HT2 receptors characterization has not been
approached in the retina, the aims of this work were to
characterize the binding sites of [3H]ketanserin in
goldfish and rabbit retina and to study the effect of
5-HT2A receptor stimulation on the in vitro regenera-
tion of the goldfish retina.
2. Methods
2.1. Materials
[3H]ketanserin was from NEN (Boston, MA, specific
activity 65.6 Ci:mmol). Serotonin (5-HT) creatinine
sulphate, Tris-[hydroxymethyl]-aminomethane (Tris–
HCl), N-2-hydroxyethylpiperazine-N-2-ethanesulfonic
acid (HEPES), poly-L-lysine, gentamicin sulphate,
guanosine 5%-triphosphate (GTP), and Leibovitz L-15
nutrient medium were from Sigma (St. Louis, MO).
The serotonin 5-HT2 receptor agonist (9 )-2,5-dime-
toxy-4-iodoamphetamine hydrochloride (DOI), the
serotonin 5-HT2 receptor antagonists ketanserin tar-
trate, mianserin hydrochloride, ritanserin, mesulergine
hydrochloride and 1-(1-naphthyl)piperazine hydrochlo-
ryde, the 5-HT1A serotonin receptor antagonist NAN-
190 hydrobromide, the 5-HT3 serotonin receptor
antagonist 3-tropanyl-3,5-dichlorobenzoate MDL-
72222, and dopamine uptake blockers nomifensine
maleate and GBR-12909 dihydrochloride, were from
Research Biochemicals Inc. (Natick, MA).
2.2. Tissue preparation
Goldfish (Carassius auratus), 4–7 cm in length were
adapted to darkness for 30 min and anesthezised in
tricaine 0.05% (Sigma) prior to dissection of the retina.
Albino New Zealand rabbits (Oryctolagus cuniculus),
0.8–1 kg were decapitated and their eyes quickly re-
moved and placed on ice, prior to the dissection of the
retina. The tissue was homogenized in a Tissumizer
(Tekmar Company, Cincinnati, OH) in ice-cold Tris–
HCl buffer 50 mM pH 7.7 centrifuged at 38 000g for
10 min at 4°C, and washed twice for removing endoge-
nous 5-HT. The final pellet was resuspended in the
incubation buffer, Tris–HCl 50 mM pH 7.7, to a
protein concentration of 0.3–0.8 mg:ml for goldfish
and 1–3 mg:ml for rabbit. For the determination of the
appropriate concentration of membranes a curve of
dilution of the preparation was carried out.
2.3. Radioligand binding assays
The binding of [3H]ketanserin was performed accord-
ing to Dewar et al. (1990) with some modifications. The
drugs were dissolved in the incubation buffer except the
first dilution of mianserin (0.1 N HCl). Membranes, 100
ml (200 mg per tube for goldfish and 700 mg:tube
for rabbit), were added to the incubation buffer, the
reaction was started by the addition of 50 ml of the
ligand, final volume 500 ml. The selectivity of the inter-
action was determined by inhibition experiments with 1
nM [3H]ketanserin in the presence of 13 concentrations
(1 nM to 1 mM) of the drugs. The saturation experi-
ments were performed with 12 concentrations of
[3H]ketanserin (0.05–to 5 nM). The specific binding
was defined by the substraction of the binding in the
presence of 150 mM mianserin from the total binding in
the absence of the inhibitor. Following a 30 min incu-
bation at 25°C membranes were separated with a
Brandel M-48 harvester onto Whatman GF:C glass
fiber filters and washed twice with 5 ml of ice-cold
binding buffer. The filters were placed in vials and
dried. Toluene:Omnifluor (0.4%, 4 ml) was added and
radioactivity was determined in a Packard liquid scintil-
lation counter Model 1900 TR (efficiency 62–65%).
Protein concentration was determined by the bicin-
choninic acid protein assay (Smith, Krohn, Hermanson,
Mallia, Gartner, Provenzano, et al., 1985).
2.4. Culture conditions and e6aluation of outgrowth
Explants from goldfish retina were prepared as previ-
ously described (Lima et al., 1994b). Briefly, 10–14
days after lesioning the optic nerve the retina was
dissected and chopped in a McIlwain tissue chopper
into 500 mm squares. A total of 10–15 explants were
placed in poly-L-lysine pre-coated flasks (25 cm2). The
nutrient medium was Leibovitz L-15, 20 mM HEPES,
10% fetal calf serum, and 0.1 mg:ml of gentamicin. All
drugs were dissolved in nutrient medium and added to
the flasks at the beginning of the culture to a final
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volume of 4 ml. The final concentrations employed were:
5-HT 50 mM, DOI 5 nM–50 mM, ketanserin, ritanserin,
mianserin and mesulergine 10 nM-50 mM, 1-(1-naph-
thyl)piperazine 10 nM–10 mM, NAN-190 1–25 mM and
tropanyl 1–100 mM. Two aspects of neuritic outgrowth
were measured: neurite density and neurite length. Neu-
rite density was scored on a scale of 0–4; a score of 0
indicated that no neurites were present at the edge of the
explants while a score of 4 was given for explants with
high fiber density. A set of four micrographies were used
as a reference. The length of the neurites was determined
with an ocular micrometer (4 objective, 8 ocular).
The evaluation of outgrowth was done at 5 days after
explantation.
2.5. Analysis of the data
The software Biodata Handling with Microcomputers
was used to calculate the concentration to produce 50%
inhibition (IC50), Hill coefficient (nH) and pseudocoeffi-
cient (pseudo-nH) (Hill, 1910; Barlow, 1983). The soft-
ware PRISM version 2.0 (GraphPad Software, Inc) was
used to analyze the saturation experiments and calculate
Bmax (maximum binding capacity) and Kd (affinity con-
stant). Kd values were also calculated by the antilog of
the log concentration of ligand giving 50% of occupation
in the Hill plot (Hill, 1910). Statistical analysis was done
with the software Biodata Handling with Microcomput-
ers (Barlow, 1983). The probability of the differences
between means was considered to be significant if PB
0.05.
3. Results
3.1. Selecti6ity of binding
Mianserin, ritanserin and DOI inhibited the interac-
tion of [3H]ketanserin to goldfish and rabbit retinal
membranes with similar potencies (Table 1). 5-HT was
a potent inhibitor of the binding to goldfish retina, but
not to rabbit retina. Nomifensine and GBR-12909 were
also potent inhibitors of the binding to goldfish mem-
branes. The inhibition curves with DOI to goldfish retina
were displaced to the right in the presence of 150 mM
nomifensine. The displacement curve of [3H]ketanserin
by DOI was not modified by GTP, was monophasic and
the Hill coefficient was 0.71. The analysis did not fit to
a two sites model, however, the pseudo-nH was less than
one for mianserin, and ketanserin in goldfish and DOI
in rabbit. In rabbit, the pseudo-nH was higher than unity
for nomifensine. In a competition control experiment
with membranes from rat striatum the IC50 of mianserin
for the binding of [3H]ketanserin was 4.5491.10 mM.
3.2. Saturation experiments
The plot of free versus specific [3H]ketanserin binding
of a series of saturation experiments gave sigmoid curves
for both species (Fig. 1a and b). The nH value was
calculated for three curves and was 2.0990.15 and
2.4090.29 for goldfish and rabbit retina, respectively.
Bmax were 432.939154.22 fmol:mg of protein for the
goldfish and 69.7996.87 fmol:mg of protein for the
rabbit retina. Kd values were 1.3490.10 nM for the
goldfish and 1.1590.12 nM for the rabbit retina.
Table 1
Inhibition of [3H]ketanserin binding to membranes from goldfish and rabbit retinasa
Goldfish Rabbit
IC50 (mM) Pseudo nH IC50 (mM) Pseudo nH
Serotonergic agents
2.6890.267.4291.120.5890.070.9690.02Ketanserin
94.7199.210.5190.0312094.95Mianserin 1.1590.27
73.90913.90 1.1290.15Ritanserin 73.66921.09 1.0790.28
125.47919.23 0.7090.08DOI 79.65935.46 0.4290.06
––0.7090.10DOInomifensine 150 mM 426.53973.03
0.7190.04DOIGTP 350 mM –81.14918.54 –
5-HT 0.8990.0132.50915.56 182.159104.40 –0.48 90.15
Uptake blockers
0.8690.03Nomifensine 233.76960.6150.90910.41 –2.0890.78
21.2793.02 –GBR-12909 0.7390.08 –
a The values are the mean9S.E.M. of three independent experiments each performed in duplicate. The inhibition of binding was determined
by incubating the membrane preparations from goldfish or rabbit retina with 1 nM [3H]ketanserin in the presence of 13 concentrations of the
corresponding unlabeled drug. The IC50 values were obtained by the iterative analysis inhibition. The pseudo-Hill coefficients (nH) were calculated
from the slope of the log[(B:BmaxB)] versus the log of the concentration of inhibiting drug (Hill, 1910).
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Fig. 1. (a) Saturation experiment of the binding of [3H]ketanserin to
goldfish retina were performed with 100 ml of membrane preparation
in the presence of 0.05–5 nM concentrations of the ligand. Specific
binding was defined by the addition of 150 mM mianserin. Incubation
was carried out at 25°C for 30 min. Values are means9S.E.M.,
n3, nH2.0990.15, Bmax:432.93 fmol:mg of protein, and Kd
1.3490.10 nM, calculated by the antilog of the log concentration
ligand giving 50% of occupation in Hill plot (Hill, 1910; Barlow,
1983). (b) Saturation experiment of the binding of [3H]ketanserin to
rabbit retina were performed with 100 ml of membrane preparation in
the presence of 0.05–5 nM concentrations of the ligand. Specific
binding was defined by the addition of 150 mM mianserin. Incubation
was carried out at 25°C for 30 min. Values are means9S.E.M.,
n3, nH2.4190.29, Bmax:69.79 fmol:mg of protein, and Kd
1.1590.12 nM, calculated by the antilog of the log concentration of
ligand giving 50% of occupation in Hill plot (Hill, 1910; Barlow,
1983).
DOI on neuritic length (Fig. 3) but not on density
(results not shown). The 5-HT1 agonist:5-HT2 sero-
tonin receptor antagonist 1-(1-naphthyl)piperazine 10
mM blocked the inhibitory effect of 50 mM DOI on
both, neuritic length and density (Table 2). The 5-HT2
antagonists mianserin and ritanserin did not block the
inhibitory effect of DOI on neuritic outgrowth. The
5-HT2C antagonist mesulergine up to 50 mM did not
block the inhibitory effect of 50 mM DOI, but in the
range of 10 nM–10 mM it blocked the inhibitory effect
of 50 mM 5-HT on neuritic outgrowth (Fig. 4).
3.4. Effect of other antagonists on the neuritic
outgrowth from goldfish retinal explants
Neither the 5-HT1A serotonin receptor antagonist
NAN-190, 100 mM, or the 5-HT3 antagonist tropanyl,
10 mM, blocked the inhibitory effect of 50 mM DOI on
neuritic outgrowth (Table 2). Treatment with 10 mM
tropanyl significantly blocked the inhibitory effect of
DOI on neuritic density, but it was seen only in three
growing explants (Table 2).
4. Discussion
An abundance of serotonergic agents is presently
available, however, none of these agents can be consid-
ered truly selective for a particular population of 5-HT
receptors (Glennon, 1991). There are few agonists
which can discriminate between 5-HT2 receptor sub-
types, and at present, it appears easier to discriminate
the individual 5-HT2 receptor subtypes using antago-
nists. Compounds such as ritanserin, LY53857, mi-
anserin and ICI17809 are essentially non-selective
whereas others, such as ketanserin and spiperone, retain
selectivity for 5-HT2A receptors (Baxter, Kennett,
Blaney & Blackburn, 1995).
[3H]ketanserin has been widely used, and it is still the
ligand of choice for the pharmacological characteriza-
Fig. 2. Effect of the 5-HT2 receptor agonist DOI on neuritic out-
growth at 5 days in culture. Each value is the mean9S.E.M. of
53–117 fibers. * PB0.05 with respect to control.
3.3. Effect of 5-HT2 agonists and antagonists on the
neuritic outgrowth from goldfish retinal explants
Control explants presented a neuritic outgrowth at 5
days after plating as shown in Fig. 2. The 5-HT2
agonist DOI, 10 nM, produced an increase of neurite
length statistically different from control (Fig. 2). At 50
mM DOI produced a decrease in the regeneration of
retinal explants. Length and density of fibers were
significantly lower as compared to control (Fig. 2;
Table 2). The 5-HT2 antagonist ketanserin was without
effect on the regeneration of retinal explants, and at 50
mM partially blocked the inhibitory effect of 50 mM
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Table 2
Inhibition of neuritic outgrowth from explants during in vitro regeneration of the goldfish retinaa
Density index nNeurite length (mm)
2.4990.04Control 28270.3590.69
5-HT2 receptor agents
1.6290.06*30.7790.98* 90DOI 50 mM
Ritanserin 10 mMDOI 50 mM 1.2390.12*,**26.6091.78*,** 21
1.6090.13*24.9991.48*,** 20Mianserin 10 mMDOI 50 mM
1-(1-naphthyl)piperazine 10 mMDOI 50 mM 2.7590.22**72.8092.21** 11
Other receptor antagonists
1.5790.28*NAN-190 25 mMDOI 50 mM 729.6192.96*
2.6790.27** 328.6592.53*Tropanyl 10 mMDOI 50 mM
a 10–15 explants were placed in poly-L-lysine precoated flasks. Medium was Leibovitz L-15 with 20 mM HEPES, 10% fetal calf serum, and 0.1
mg:ml of gentamicin. At 5 days after plating, two aspects of neuritic growth were measured: neurite length and neurite density. Neurite density
was scored on a scale of 0–4. 0 indicated absence of neurites and 4 a high fiber density. The length of neurites was determined with an ocular
micrometer (4 objective, 8 ocular). n, number of explants with neurites. For controls n represents 85–90% of attached explants; for other
conditions n represents 30–80% of attached explants.
* PB0.05 with respect to control.
** PB0.05 with respect to 50 mM DOI.
tion of 5-HT2 receptors, with higher selectivity for the
5-HT2A subtype (Cortijo et al., 1997). In the retina of
goldfish and rabbit, [3H]ketanserin binding shows posi-
tive cooperativity. At the present there is no description
of positive cooperativity for a G protein coupled recep-
tor in the retina. It has been reported that positive
cooperativity in muscarinic cholinergic antagonist bind-
ing can be induced by guanine nucleotides (Boyer,
Martı´nez-Carcamo, Monroy-Sa´nchez, Posadas & Gar-
cı´a-Sainz, 1986). As 5-HT2 receptors are coupled to a
G-protein, the displacement of [3H]ketanserin by the
agonist DOI was expected to be biphasic and modified
by GTP, instead, displacement curves were not changed
in the presence of GTP. A weak coupling to guanine
nucleotide regulatory proteins has been shown for 5-
HT2 receptors in rat frontal cortex, with only a small
change in agonist affinity and little or no change in
pseudo-Hill coefficient (Shearman & Strange, 1988).
Our results can be explained by: (1) The proportion of
high-affinity sites seen in the displacement of
[3H]ketanserin by the agonist is too small to be detected
by this ligand (Sleight, Stam, Mutel & Vanderheyden,
1996); (2) In the goldfish retina [3H]ketanserin binds to
a monoamine transporter as has been described in
other tissues (Dewar et al., 1990).
It has been shown that experimental conditions can
affect the interaction of a ligand with its binding site.
For example, cell disruption causes marked changes in
the kinetics of b-adrenergic receptor binding from a
positive cooperative to a non-cooperative state without
changing the number of sites (Maderspach & Fajszi,
1982). The positive cooperativity seen in our study
could be due to experimental conditions used, to a
particular retinal membrane microenvironment or to
the binding of [3H]ketanserin to a non-5-HT2A site. The
IC50 obtained by inhibition experiments gave values for
agonists and antagonists in both species higher than
those reported for the brain. Similar results have been
obtained for agonists and antagonists of D1 and D2
receptors (Redburn, Clement-Cormier & Lam, 1980)
and for serotonergic agents on [3H]5-HT (Lima, Radtke
& Drujan, 1992), and [3H]DPAT (Lima et al., 1994a)
binding to membranes from goldfish retina. The IC50
value obtained for mianserin in our control experiment
with rat striatum is in good agreement with other
studies on the same brain area in rat (Roth, McLean,
Zhu & Chuang, 1987) and rabbit (Dewar et al., 1990)
and suggests that differences are not due to the method-
ology applied. Such significant variations have been
described in the pharmacology of the species homo-
logues of the 5-HT2 receptors. For example, the mouse
5-HT2B receptor possesses an approximately 100-fold
Fig. 3. Effect of the 5-HT2 receptor antagonist ketanserin on growth
inhibition by the agonist DOI at 5 days in culture. Each value is the
mean9S.E.M. of 2–131 fibers. a PB0.05 with respect to control.
b PB0.05 with respect to DOI.
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Fig. 4. Effect of the 5-HT2 receptor antagonist mesulergine on growth
inhibition by 5-HT at 5 days in culture. Each value is the mean9
S.E.M. of 23–86 fibers. a PB0.05 with respect to control. b PB0.05
with respect to 5-HT.
ing rat hepatocytes, 5-HT can act as a potent comito-
gen and induce DNA synthesis probably through
5-HT2 receptors (Balasubramanian & Paulose, 1998).
The role of 5-HT on outgrowth has been investigated in
goldfish retinal explants, and it was shown that 5-HT
itself, serotonergic agonists and uptake blockers de-
crease the axonal outgrowth, an effect probably medi-
ated through 5-HT1A which seem to be present in this
tissue (Lima et al., 1994a,b). Based on this previous
results, and the presence of 5-HT2 receptors in the
goldfish retina, as suggested by electrophysiological
studies (Hensley & Cohen, 1992), we evaluated if 5-HT
acting through 5-HT2A receptors could modify neuritic
outgrowth of this tissue in vitro.
In this study, the 5-HT2A:5-HT2C agonist DOI
showed a dual effect, stimulating outgrowth at low, and
inhibiting it at high concentrations. The inhibitory ef-
fect was partially blocked by the specific 5-HT2A antag-
onist ketanserin and by the 5-HT1 agonist:5-HT2
antagonist 1-(1-naphthyl)piperazine, but not by mi-
anserin or ritanserin. It is known that the electrophysio-
logical activity plays a role in the in vitro regeneration
of the goldfish optic nerve, abolishing it can modify the
availability of a large array of axonally transported
proteins (Antonian, Perry & Grafstein, 1987), which
might interfere with various aspects of regeneration like
axonal adhesivity. Some serotonergic agents can modify
electrophysiological activity, and in particular, the 5-
HT2A:2C agonist DOI induces an inhibitory response of
the spontaneous activity of rat cerebellar dentate:inter-
positus neurons in vitro (Cumming-Hood, Strahlendorf
& Strahlendorf, 1993). A modification of the electro-
physiological activity by DOI could play a role in the
described inhibition of retinal outgrowth. The lack of
effect of mianserin and ritanserin in inhibiting DOI
effect is consistent with other observations that some
5-HT2 antagonists in central nervous tissues, like cypro-
heptadine, have little effect in the retina and other eye
structures (Osborne, Fitzgibbon, Liu, Leslie &
Cholewinski, 1993). In addition, the absence of effect of
mesulergine on the inhibition of retinal outgrowth in
the presence of DOI, but not on the inhibitory effect of
5-HT might suggest that 5-HT acts on more than one
member of 5-HT2 family of receptors, probably a 5-
HT2C binding sites, and also shows that the effect of
DOI inhibited by ketanserin is mediated through 5-
HT2A receptors. The specificity of 5-HT and DOI ef-
fects could be confirmed by the fact that serotonergic
antagonists selective for other 5-HT receptors were
unable to block them.
The mechanisms underlying the effects presented in
this report are still not defined, but DOI has been
shown to induce phosphoinositide hydrolisis in cerebel-
lar granule neurons, among others (Chen, Li &
Chuang, 1995). Moreover, DOI induces cAMP accu-
mulation in a neuronal cell line derived from embryonic
lower affinity for 5-HT than either the rat or the human
homologue and the affinity order of potency 5-HT\5-
CT observed in both rat and human is reversed in the
mouse (Baxter et al. 1995). Some differences in the
protein structure could account for a reduced affinity of
the compounds for the binding sites. It has been shown
that a single point mutation can abolish agonist and
antagonist binding to 5-HT2 receptors. For example,
[3H]ketanserin binding affinity is diminished by the
Phe339Leu339 mutation, and the affinities of mesu-
lergine, methysergide, and lisuride by the Phe340
Leu340 mutation (Choudhary, Craigo & Roth, 1993).
Displacement to the right of [3H]ketanserin binding
inhibition curve by DOI in the presence of nomifensine
and GBR-12909, might indicate that this ligand also
binds to a monoamine transport site in membranes
from the goldfish retina, and seems to represent most of
the sites labeled. In the rabbit retina, nomifensine did
not inhibit [3H]ketanserin binding component, and
makes to suggest, that in this tissue binding to such a
transport site represents only a small part of the total
binding. As mentioned above, [3H]ketanserin has been
reported to bind to a monoamine transporter in rabbit
cerebral cortex and neostriatum (Dewar et al., 1990).
The differences observed between [3H]ketanserin
binding sites in various preparations seem to be species
related, and might represent differences in the structure
of membrane proteins or in the microenvironment in
each tissue.
5-HT has been reported to act as a neurotrophic
agent during development and regeneration in rat (Liu
& Lauder, 1991). In cell cultures from the molusc
Helisoma, 5-HT inhibits the neurite outgrowth of spe-
cific identified neurons, B19, and C1 (Murrain, Murphy,
Mills & Kater, 1990). In primary cultures of regenerat-
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rat cortex by protein kinase C dependent and calcium:
calmodulin dependent mechanisms (Berg, Clarke,
Chen, Ebersole, McKay & Maayani, 1994). Modula-
tion of cAMP levels has been suggested to play a role in
the inhibition of axonal outgrowth induced by 5-HT
and some serotoninergic agonists during regeneration
of the goldfish retina (Urbina et al., 1996). This report
supports the role of 5-HT as a modulator in the process
of in vitro neuronal regeneration of the goldfish retina,
and shows that more than one receptor subtype may
mediate this effect.
5. Conclusions
The present results make to suggest an interaction of
[3H]ketanserin with binding sites, probably 5-HT2A re-
ceptors present in the rabbit retina. In the goldfish
retina [3H]ketanserin binds, in addition, to a site which
seems to be a monoamine transporter. However, the
inhibitory effect elicited by the 5-HT2A:5-HT2C agonist
DOI on neuritic outgrowth and the partial blockade by
ketanserin and 1-(1-naphthyl)piperazine suggest an in-
teraction with sites belonging to the 5-HT2 receptor
family. According to these results, [3H]ketanserin does
not seem to be a suitable ligand for the pharmacologi-
cal characterization of 5-HT2 receptors possibly present
in the goldfish retina. The use of other ligands and
molecular biology techniques like Northern blot analy-
sis (Deecher, Wilcox, Dave, Rossman & Kimelberg,
1993) could give additional evidence to support the
results presented in this work.
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